Also trades as: LONN.SW (SIX) · $vol 96M · 0QNO.L (LSE) · $vol 53M · LZAGF (OTC) · $vol 0M

$68.22

+1.00 (+1.49%)

Weekly Expected Move ±3.6%

$63 $66 $68 $71 $73

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $48.5B mcap · 70M float · 0.071% daily turnover · Short 55% of daily vol

Revenue

$6.2B -5.1% ▼

5Y CAGR: +6.7%

Gross Profit

$2.3B +6.9% ▲

5Y CAGR: +6.2%

Operating Income

$1.3B +35.9% ▲

5Y CAGR: +7.8%

Net Income

$949M +49.2% ▲

5Y CAGR: +1.8%

EPS (Diluted)

$1.35 +51.7% ▲

5Y CAGR: +3.1%

EBITDA

$1.3B -15.0% ▼

5Y CAGR: -1.6%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$5.4B	$6.2B	$6.7B	$6.6B	$6.2B
YoY Growth	+20.0%	+15.0%	+7.9%	-2.1%	-5.1%
Cost of Revenue	$3.4B	$3.9B	$4.8B	$4.4B	$4.2B
Gross Profit	$2.0B	$2.3B	$1.9B	$2.2B	$2.3B
Gross Margin	36.4%	37.0%	29.0%	32.9%	37.0%
R&D Expenses	$185M	$95M	$105M	$0	$0
SG&A Expenses	$754M	$827M	$837M	$945M	$877M
Operating Expenses	$1.3B	$897M	$1.1B	$1.2B	$966M
Operating Income	$851M	$1.5B	$880M	$964M	$1.3B
Operating Margin	15.7%	24.8%	13.1%	14.7%	21.0%
Interest Expense	$77M	$76M	$93M	$176M	$162M
Income Before Tax	$760M	$1.4B	$790M	$754M	$1.1B
Tax Expense	$83M	$230M	$135M	$117M	$192M
Net Income	$2.9B	$1.2B	$654M	$636M	$949M
Net Margin	54.4%	19.5%	9.7%	9.7%	15.2%
EPS (Diluted)	$3.95	$1.63	$0.89	$0.89	$1.35
EBITDA	$1.3B	$2.0B	$1.5B	$1.5B	$1.3B
Shares Outstanding	745M	744M	737M	713M	702M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$3.2B	$3.1B	$3.6B	$3.1B	$3.5B	$3.6B	$3.0B	$3.4B
Cost of Revenue	$2.0B	$2.0B	$2.8B	$1.9B	$2.5B	$2.3B	$1.9B	$2.1B
Gross Profit	$1.2B	$1.1B	$840M	$1.1B	$1.0B	$1.3B	$1.0B	$1.3B
Gross Margin	38.3%	36.0%	23.1%	36.5%	29.7%	36.1%	34.4%	38.4%
R&D Expenses	$186M	$0	$194M	$0	$0	$0	$0	$0
SG&A Expenses	$346M	$497M	$340M	$540M	$405M	$667M	$315M	$501M
Operating Expenses	$346M	$497M	$571M	$582M	$614M	$675M	$276M	$501M
Operating Income	$896M	$611M	$269M	$534M	$430M	$617M	$703M	$822M
Operating Margin	27.6%	19.9%	7.4%	17.5%	12.2%	17.3%	23.8%	23.9%
Interest Expense	$34M	$31M	$28M	$52M	$124M	$66M	$83M	$58M
Income Before Tax	$854M	$486M	$304M	$395M	$359M	$525M	$527M	$723M
Tax Expense	$134M	$75M	$60M	$65M	$52M	$99M	$92M	$139M
Net Income	$723M	$410M	$244M	$329M	$307M	$426M	$523M	$604M
Net Margin	22.3%	13.3%	6.7%	10.8%	8.7%	11.9%	17.7%	17.5%
EPS (Diluted)	$0.97	$0.55	$0.34	$0.46	$0.43	$0.61	$-0.99	$0.86
EBITDA	$1.2B	$899M	$633M	$824M	$718M	$1.0B	$905M	$1.2B
Shares Outstanding	743M	743M	727M	714M	713M	702M	702M	699M

LZAGY OTC